2025-04-28 22:36:26
Latest Post
Indegene Limited recommends final dividend of Rs. 2
Suraj Industries Ltd subsidiary commences commercial production at its bottling plant
KFin Technologies Limited recommends final dividend of Rs. 7.50
Plastiblends India Ltd recommends dividend of Rs. 2.50
Consolidated Construction Consortium Ltd Q4 FY25 consolidated profit at Rs. 55.92 crores
Stock Report
Vimta Labs Ltd to invest Rs. 50 crores to Biologics CDMO business foray
Posted On : 2025-04-28 18:40:17( TIMEZONE : IST )
The Board of Directors of Vimta Labs Ltd have approved, Company's foray into Biologics Contract Research and Development activities (CDMO), subject to Shareholder's approval.
The industry or area to which the new line of business belongs to is Biologics Contract Research and Development.
The foray into this new segment will help Vimta to enter into the growing CDMO business of biologics and peptides, that will strengthen our service portfolio to biopharmaceutical industry, enabling acceleration of our business growth.
The estimated amount to be invested in the new business is Rs. 50 Cores.
Shares of Vimta Labs Limited was last trading in BSE at Rs. 1021.10 as compared to the previous close of Rs. 1087.70. The total number of shares traded during the day was 17391 in over 2093 trades.
The stock hit an intraday high of Rs. 1158.95 and intraday low of 998.35. The net turnover during the day was Rs. 18626994.00.
